U.S. MARKETS FOR APHERESIS, HEMOSTASIS, AND STEM CELL THERAPY PRODUCTS

In 2001, the U.S. apheresis, hemostasis, and stem cell therapy products market totaled $580.2 million, a figure that is expected to more than double over the forecast period covered by this report. Technologies such as blood modification, salvaging, and substitution; stem cell expansion and transplantation; and therapeutic apheresis will drive market growth.

This report from Medtech Insight presents a detailed overview of apheresis, hemostasis, and stem cell therapy technologies and markets, along with 15 company profiles.